Addition of bevacizumab to paclitaxel/carboplatin in first-line management of advanced ovarian cancer: Results of the GOG 0218 phase III study

Kristin Garcia, Aarati Ranganathan, Robert L. Coleman

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Addition of bevacizumab to paclitaxel/carboplatin in first-line management of advanced ovarian cancer: Results of the GOG 0218 phase III study'. Together they form a unique fingerprint.